Guidance Provided for Safe Use of Ketamine
By Elana Gotkine HealthDay Reporter
TUESDAY, Feb. 25, 2025 -- Administration of ketamine for purposes other than acute pain management and procedural sedation should be subject to the same prescribing guidelines as other sedating medications, according to new guidance released by the American Society of Anesthesiologists (ASA).
The ASA notes that ketamine prescriptions are being written by health care professionals who are not trained in safe administration of anesthetic medications and that patients treated with ketamine at outpatient clinics or in their home may not have access to vital sign monitoring, rescue personnel, or emergency resuscitation equipment. For these reasons, the ASA has developed recommendations for the administration of ketamine outside of acute pain management and procedural sedation.
The ASA believes that the general principles for use of ketamine for indications other than anesthesia should follow the same general prescribing principles as other sedating medications. Ketamine should be prescribed as part of a comprehensive treatment plan by an appropriately trained and licensed medical professional who conducts periodic face-to-face visits. A therapeutic end point and defined treatment course should be provided for ketamine treatment. Steps should be taken to ensure use of ketamine therapy as prescribed, and medical professionals should be aware of diversion to nonmedical purposes. The minimum dose necessary to achieve a desired clinical effect should be prescribed. Patients should receive education regarding possible adverse effects of ketamine. Apart from when it is used as a procedural anesthetic, ketamine should not be administered in doses that produce excessive sedation, unconsciousness, or unresponsiveness.
"People who have struggled with mental health issues and are understandably excited about a new treatment may not realize that they are risking their lives by receiving treatment without medical supervision in unaccredited clinics or offices without established safety standards," Donald E. Arnold, M.D., president of the ASA, said in a statement.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-02-26 06:00
Read more

- Senators Call on FDA to Act Against Misleading Weight-Loss Drug Commercials
- Effect of Behavioral Intervention on Reducing Care Overuse in Seniors Not Sustained
- Study Finds No Spike in Cardiac Arrest in Athletes During Pandemic
- Firearms Injuries Shot Up Following Pandemic, Study Says
- NIH-Funded Clinical Trial Will Evaluate New Dengue Therapeutic
- Physical Activity Linked to Attenuation of Colon Cancer Survival Disparity
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions